Fulvestrant Sandoz 250 mg/5 ml
Fulvestrant Sandoz 250 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 65651. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 October 2015 and the authorisation is valid without a time limit. ATC code L02BA03 places the medicine in the group Endocrine therapy.
| Authorisation number | 65651 |
|---|---|
| Name | Fulvestrant Sandoz 250 mg/5 ml |
| Full name | Fulvestrant Sandoz 250 mg/5 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BA03 |
| First authorisation | 23 October 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Fulvestrant Sandoz 250 mg/5 ml, Injektionslösung in einer Fertigspritze | B | 23 October 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 2 | Fertigspritze(n) | L02BA03 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Fulvestrant Sandoz 250 mg/5 ml authorised in Switzerland?
Yes. Fulvestrant Sandoz 250 mg/5 ml is authorised by Swissmedic under authorisation number 65651, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Fulvestrant Sandoz 250 mg/5 ml have?
Fulvestrant Sandoz 250 mg/5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Fulvestrant Sandoz 250 mg/5 ml?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.